2024 annual financial data
Vir Biotechnology 2024 Net margin
Direct answer
Net margin was -703.4%.
Operating income was -587,165,000 USD and net income was -521,960,000 USD.
Operating cash flow was -446,352,000 USD.
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 74,205,000 USD
- Operating income
- -587,165,000 USD
- Net income
- -521,960,000 USD
- Operating cash flow
- -446,352,000 USD